Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Medieval Remedy Found to be Highly Effective Against MRSA

By Drug Discovery Trends Editor | March 31, 2015

A page from Bald’s Leechbook (Credit: British Library, Wikimedia)Could a centuries-old remedy help treat modern-day bacteria, Methicillin-resistant Staphylococcus (MRSA)?

While it sounds far-fetched, there is truth to the concept.

British researchers recently found that a thousand-year-old Anglo-Saxon treatment for eye infections works as an antibiotic against MRSA. MRSA kills more than 5,000 people each year in the U.S.

Christina Lee, a professor in Viking studies at the University of Nottingham, translated the 10th-century recipe — which called for garlic, onion, wine and bile from a cow’s stomach to be brewed in a brass vessel — from a leather-bound volume of Bald’s Leechbook, one of the earliest known medical books.

Lee then enlisted the help of the university’s microbiologists. Microbiologist Freya Harrison, who led the work in the lab at the School of Sciences, and others tested the medieval recipe on cultures of MRSA.

And although the researchers weren’t holding out much hope, “We were genuinely astonished at the results of our experiments in the lab,” Lee said in a press release. The combined ingredients killed nearly all the cells: only about one in 1,000 bacteria survived. The researchers duplicated similar results in three more batches, and U.S. collaborators were successful when they tested the recipe using an “in vivo” wound model.

The team says it now has positive, replicated data showing that the remedy kills up to 90 percent of MRSA bacteria in “in vivo” wound biopsies from mice, reports CNN.

“Obviously you can never say with utter certainty that because it works in the lab it’s going to work as an antibiotic,” said Harrison. “But the potential of this to take on to the next stage and say, ‘yeah, it really does work as an antibiotic’ is just beyond my wildest dreams, to be honest.”

The research results were presented at the Annual Conference of the Society of General Microbiology, in Birmingham yesterday.

 

Establish your company as a technology leader. For 50 years, the R&D 100 Awards, widely recognized as the “Oscars of Invention,” have showcased products of technological significance. Learn more. 


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50